VERU INC. (ticker: VERU) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of VERU's SEC filings surfaces 4 active risk signals, including 2 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. VERU reported $0 in revenue and -$8.07M for the period ending 2025-06-30, with operating cash flow of -$15.08M. Cash and equivalents stood at $27.60M (up 37.9% year-over-year). Total assets of $43.08M exceed total liabilities of $8.30M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
VERU Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for VERU INC. (VERU) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.